MedPath

Impact of Spiroergometer Parameters as Diagnostic Marker of Cardiac Ischemia in Pts. With Stable Angina Compared to FFR.

Conditions
Stable Angina
Registration Number
NCT04450459
Lead Sponsor
Jena University Hospital
Brief Summary

In Patients with stable Angina pectoris CCS 1-3 exercise testing for ischemia detection is widely used despite the known limitations. Measurement of the FFR is invasive but gold standard for Ischemia detection.

Adding of parameters of spiroergometer might help to improve diagnostic accuracy of non invasive exercise testing. Therefore the trial is evaluating diagnostic accuracy of spiroergometric parameters compared to invasive FFR measurement.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • stable Angina (CCS >1-3) with suspected CAD or
  • dyspnoea at exertion NYHA >2 or
  • signs of ischemia within SPECT or exercise electrocardiography
  • willingness to participate in the trial
Exclusion Criteria
  • Unstable angina or myocardial infarction within the last 2 weeks
  • inability to perform bicycle exercise test
  • significant valvular disease
  • HOCM
  • av- block >I degree
  • asthma bronchiales

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
double slope sign of ΔV̇O2/ΔWR-Increasebaseline

double slope sign of ΔV̇O2/ΔWR by ergospirometer test

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Universityhospital

🇩🇪

Jena, Germany

© Copyright 2025. All Rights Reserved by MedPath